- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Nanotechnology for Surgical Success and Phototherapy in Cancer
Scientists at Oregon State University have developed fluorescent nanoparticles that can aid in the removal of malignant tumors and also kill any remaining malignant cancer cells.
Researchers at Oregon State University have developed a new way to selectively insert compounds into cancer cells—a system that will help surgeons identify malignant tissues and then, in combination with phototherapy, kill any remaining cancer cells after a tumor is removed.
It's about as simple as, "If it glows, cut it out." And if a few malignant cells remain, they'll soon die.
The findings, published in the journal Nanoscale, have shown remarkable success in laboratory animals. The concept should allow more accurate surgical removal of solid tumors at the same time it eradicates any remaining cancer cells. In laboratory tests, it completely prevented cancer recurrence after phototherapy.
Link to the complete report: http://bit.ly/1KhT7RJ
Source: Phys.org
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
